| Line Item | 2025-12-27 | Y/Y |
|---|---|---|
| Revenue | $7.25B | +15.1% |
| Cost of Revenue | $2.99B | +15.0% |
| Gross Profit | $4.26B | +15.1% |
| R&D Expense | $1.13B | +13.3% |
| SG&A Expense | $1.25B | +13.1% |
| Operating Income | $1.88B | +17.7% |
| Pre-tax Income | $2.01B | +18.8% |
| Income Tax | $350.6M | +23.5% |
| Net Income | $1.66B |
| Line Item | 2025-12-27 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.28B | +9.6% |
| Accounts Receivable | $1.25B | +27.4% |
| Inventory | $1.77B | +20.2% |
| Current Assets | $6.25B | +17.1% |
| Total Assets | $10.99B | +14.2% |
| Current Liabilities | $1.72B | +14.1% |
| Stockholders' Equity | $8.97B | +14.3% |
| Line Item | 2025-12-27 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.63B | +14.0% |
| Capital Expenditures | $270.4M | +39.7% |
| Investing Cash Flow | -$645.2M | -64.0% |
| Financing Cash Flow | -$844.1M | -34.7% |
| Free Cash Flow | $1.36B | +10.0% |
| +17.9% |
| EPS (Basic) | $8.65 | +17.7% |
| EPS (Diluted) | $8.59 | +17.7% |